Moyes; Christopher R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moyes; Christopher R..The latest application filed is for "glucose-responsive insulin conjugates".

Company Profile

1.7.12

Moyes; Christopher R. - Westfield NJ
Moyes; Christopher R. - Westfiled NJ
MOYES; Christopher R. - Kenilworth NJ US
Moyes; Christopher R. - Hertford GB
Moyes; Christopher R. - Hertfordshire GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glucose-responsive Insulin Conjugates App 20220273770 - Feng; Danqing ; et al.	2022-09-01
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes Grant 11,041,009 - Feng , et al. June 22, 2	2021-06-22
Glucose Responsive Insulin Comprising A Tri-valent Sugar Cluster For Treatment Of Diabetes App 20200087375 - Feng; Danqing ; et al.	2020-03-19
Glucose-responsive insulin conjugates Grant 9,884,125 - Lin , et al. February 6, 2	2018-02-06
Glucose-responsive Insulin Conjugates App 20160303244 - Lin; Songnian ; et al.	2016-10-20
Glucose-responsive Insulin Conjugates App 20160251407 - Lin; Songnian ; et al.	2016-09-01
Glucose-responsive Insulin Conjugates App 20150105317 - Lin; Songnian ; et al.	2015-04-16
Pyrrolidine derived beta 3 adrenergic receptor agonists Grant 8,604,038 - Edmondson , et al. December 10, 2	2013-12-10
Pyrrolidine derived beta 3 adrenergic receptor agonists Grant 8,354,403 - Edmondson , et al. January 15, 2	2013-01-15
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20120225886 - Edmondson; Scott D. ; et al.	2012-09-06
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20120157432 - Edmondson; Scott D. ; et al.	2012-06-21
Heterocyclyl-substituted Anti-hypercholesterolemic Compounds App 20100069347 - Morriello; Gregori J. ; et al.	2010-03-18
Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity Grant 7,598,243 - Butora , et al. October 6, 2	2009-10-06
A Method of Treating Cancer App 20090012061 - Blizzard; Timothy A. ; et al.	2009-01-08
Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity App 20080081803 - Butora; Gabor ; et al.	2008-04-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.